{"custom_id":"syn8016650","method":"POST","url":"/v1/chat/completions","body":{"model":"gpt-4o","messages":[{"role":"system","content":"You are Syndi, a highly competent and helpful data assistant."},{"role":"user","content":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn8016650\n\n##TRAPping the metabolic adaptations of plexiform neurofibroma\n**Initiative:** Open\n&nbsp;\n**Names:** Giorgio Colombo, Ph.D.; Andrea Rasola, Ph.D., M.S.\n**Contact Email:** giorgio.colombo@gmail.com; andrea.rasola@unipd.it\n**Dates:** 1/1/2017 to 12/31/2019\n**Tumor Focus:** plexiform neurofibromas, MPNST\n**Application**:  preclinical, translational\n&nbsp;\n**Background:** \nPlexiform neurofibroma (PN) is a complex tumor that develops within perineural sheaths of nerve bundles in neurofibromatosis type I (NF1) patients. Albeit benign, PNs can be disfiguring, can dangerously compress surrounding tissues or undergo transformation into highly aggressive sarcomas termed malignant peripheral nerve sheath tumors (MPNSTs). PN formation and growth require mutations at the NF1 gene, leading to loss of the Ras GTPase activating protein (Ras-GAP) neurofibromin and to the ensuing induction of the Ras/ERK transduction axis. Oncogenic signalling via the Ras/ERK pathway contributes to the metabolic rewiring of tumor cells, a crucial hallmark of neoplastic transformation. In tumor cells changes in mitochondrial activity lead to accumulation of oncometabolites, such as succinate, that prompt neoplastic growth via regulation of transcription factors or epigenetic changes. The role of metabolism in PN formation or in PN transformation into MPNST was never investigated. We have previously shown that in tumor cells the Ras/ERK transduction pathway has a mitochondrial branch, and that the mitochondrial chaperone TRAP1 increases intracellular succinate, thus activating the tumorigenic programs mastered by the transcription factor HIF1. These observations suggest the possibility that hyperactive ERK might target TRAP1 in mitochondria of PN cells, thus leading to succinate-dependent, pro-neoplastic HIF-1 activation. \n&nbsp;\n**Goals of Project:** \nThis project aims at investigating the possibility that hyperactive Ras/ERK signalling could contribute to pro-neoplastic metabolic rearrangements in mitochondria of neurofibroma cells by regulating TRAP1 chaperone activity, thus crucially contributing to the processes of growth and malignant transformation of PNs. We will dissect the mode of action of TRAP1, connecting it with the metabolic status of PNs and MPNSTs, which will be thoroughly investigated in in vivo tumor models.\n&nbsp;\n**Methods:**\nStarting from these premises, we will design allosteric TRAP1 inhibitors to be tested as putative anti-neoplastic compounds on PN and MPNST models. Analysis of structure-dynamics-function relationships for complexes between TRAP1 and nucleotides or small ligands will be carried out in order to achieve a computational characterization of allosteric mechanisms of regulation of TRAP1 chaperone activity, and to find out druggable sites. This information will be translated into pharmacophore models that will be first used to screen drug libraries. Analysis of the efficacy of the selected compounds as TRAP1 allosteric inhibitors will be studied by a stepwise in vitro, in cell and in vivo approach, leading to the use of first generation molecules as leads for the design and synthesis of potentially more powerful derivatives\n &nbsp;\n**Impact:**  To gain insight on the mode of action and role of TRAP1, with regards to PN and MPNST metabolism.  \n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954708\nName: ATP hydrolisis rate\nSummary:\n- Assays: ATPase activity assay\n- Species: Homo sapiens, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, \n- Data types: exel\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig36B hydrolysis.xlsx, fig36C hydrolysis-subparticle.xlsx\n\n\n\n2. ID: syn64954709\nName: CRC\nSummary:\n- Assays: calcium retention capacity assay\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1\n- Data types: exel\n- File formats present: excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig37A CRC.xlsx\n\n\n\n3. ID: syn64954710\nName: NADH dehydrogenase activity\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Fig.22_complexI.xlsx\n\n\n\n4. ID: syn64954711\nName: OCR and ECAR\nSummary:\n- Assays: oxygen consumption assay, \n- Species: Homo sapiens, Danio rerio, \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, \n- Data types: exel, excel, \n- File formats present: excel, \n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: fig13rowdataOCR.xlsx, fig14rowdataOCR.xlsx, Figure 44 B.xlsx, Fig.8-9_Seahorse.xls, Fig.10_Seahorse.xls\n\n\n\n5. ID: syn64954712\nName: SDH activity\nSummary:\n- Assays: sorbitol dehydrogenase activity level assay\n- Species: Mus musculus, Homo sapiens, Danio rerio\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: NF1, , Malignant Peripheral Nerve Sheath Tumor\n- Data types: csv, excel, jpg\n- File formats present: csv, , jpg\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: SDH activity TRAP1 inhibitors.csv, cisMPNST SDH activity TRAP1 inhibitors.csv, S462 SDH activity TRAP1 inhibitors.csv, PN 95.6 SDH activity TRAP1 inhibitors.csv, cisMPNST dose-dependent SDH activity TRAP1 inhibitors.csv\n\n\n\n6. ID: syn64954713\nName: SDS and BN-PAGE\nSummary:\n- Assays: SDS-PAGE, blue native PAGE, immunoprecipitation, , gel filtration chromatography\n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: , NF1\n- Data types: , word, exel, ppt\n- File formats present: , word, excel\n- Funders: NTAP\n- Contains data created by: Andrea Rasola\n- Example files present: Purification recombinant human TRAP1_Batch 4.tif, Coomassie blue staining_purification human recombinant TRAP1_Batch 4.png, Fig31C BNP.docx, Fig34B IP.docx, Fig34B IP.xlsx\n\n\n"}],"max_tokens":6000}}